Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-200,683
Closed -$3.82M 209
2026
Q1
$3.82M Buy
+200,683
New +$3.88M 0.06% 97
2025
Q3
Sell
-124,535
Closed -$2.52M 185
2025
Q2
$2.52M Hold
124,535
0.06% 105
2025
Q1
$1.71M Sell
124,535
-56,365
-31% -$776K 0.04% 117
2024
Q4
$2.14M Hold
180,900
0.05% 107
2024
Q3
$3.25M Buy
+180,900
New +$3.3M 0.08% 95
2020
Q4
Sell
-42,171
Closed -$1.76M 639
2020
Q3
$1.76M Buy
+42,171
New +$1.93M 0.04% 259
2020
Q1
Sell
-77,000
Closed -$2.95M 635
2019
Q4
$2.95M Buy
+77,000
New +$2.89M 0.08% 199

Other funds holding XP

Barings's XP Position: Q2 2026 in Review

Barings sold out of XP (XP) in Q2 2026, closing a stake of 200,683 shares — an estimated $3.82M sold.

Barings first reported a position in XP in Q4 2019 and held it in 7 quarters. The position peaked at $3.82M in Q1 2026. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Barings reported no remaining XP position as of Q2 2026 after selling out during the quarter.
  • Barings sold 200,683 XP shares in Q2 2026, an estimated $3.82M.
  • Barings first reported a position in XP in Q4 2019 and held it in 7 quarters.
  • Barings's XP position peaked at $3.82M in Q1 2026.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Barings's 13F filing for Q2 2026, filed 7 Aug 2026.